Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management

Sandra M Swain1, Joseph C Arezzo

  • 1Washington Cancer Institute, Washington Hospital Center, Washington, DC 20010, USA. sandra.m.swain@medstar.net

Insights

Microtubule inhibitor chemotherapies for breast cancer can cause peripheral neuropathy. Newer agents and dose adjustments may reduce neurotoxicity risks and improve patient outcomes.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Microtubule inhibitors (MTIs) like vinca alkaloids, taxanes, and epothilones are crucial in breast cancer treatment.
  • These therapies are frequently linked to chemotherapy-induced peripheral neuropathy (CIPN).
  • CIPN incidence and severity vary based on the specific MTI, dosage, schedule, and patient factors.

Purpose of the Study:

  • To review the incidence, characteristics, and management of MTI-associated neurotoxicities.
  • To compare neuropathy profiles of older versus newer MTIs in breast cancer therapy.
  • To provide insights into managing MTI-induced peripheral neuropathy.

Main Methods:

  • Literature review of MTI-based chemotherapies for breast cancer.
  • Analysis of reported peripheral neuropathy incidence and characteristics for vinca alkaloids, taxanes, and epothilones.
  • Examination of management strategies including dose adjustments and treatment delays.

Main Results:

  • Vinca alkaloids: Older agents (vincristine) caused severe neuropathy; newer agents (vinflunine) show milder, distal sensory deficits.
  • Taxanes: Paclitaxel and albumin-bound paclitaxel are more associated with sensory neuropathy than docetaxel.
  • Epothilones: Ixabepilone generally causes mild to moderate, reversible neuropathy, unlike potential grade 3/4 neuropathy with other epothilones.

Conclusions:

  • MTI-based therapies present a risk of peripheral neuropathy in breast cancer patients.
  • Newer MTIs like vinflunine and ixabepilone may offer improved neurological safety profiles.
  • Effective management involves careful monitoring, dose modification, and treatment delay to mitigate neurotoxicity.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...